The Marketing Senior Manager, General Medicine, Value Strategy & Marketing will support the development and delivery of the value marketing strategy for omecamtiv mecarbil in heart failure. They will lead the development of tools and resources to communicate the disease burden, clinical efficacy and safety, and economic value messages to gain coverage with formulary decision-makers, and support value-based initiatives.
Key job responsibilities will include:
Develop and execute tools/resources to optimally communicate a product’s value proposition to maintain or improve coverage, support value-based initiatives, and deliver on value marketing strategy.
Work cross functionally with the Coverage & Pricing (C&P) team, Global Health Economics (GHE), Center for Observational Research (CfOR), U.S. medical teams including medical communication and brand marketing on data generation and creation of the U.S. Value Communication platform.
Work with third-party vendors to facilitate the internal legal, regulatory and medical review of marketing materials via the Materials Approval and Compliance (MAC).
Effectively rollout and train the Market Access team (field account executives) on programs and resources. Provide support to field staff to address questions.
Lead bi-weekly or monthly Value/Global Health Economics alignment meetings.
Lead annual value summit to solicit cross functional feedback on data evidence generation needs to address future challenges.
Develop training around key competitive events related to value. This will include response to ICER (Institute for Clinical and Economic Review) reports related to Inflammation products and/or nephrology products.
Align and/or lead cross-functional workstreams to support business initiatives for payers.
Support development of value-marketing plans aligned with coverage & pricing and overall brand strategic plans.
Partner on market research with cross-functional partners to generate deep payer customer, competitive, and marketplace insights
Develop and manage the value marketing budget.
5-10% travel may be required.
Strong business insight, analytical skills, and ability to think strategically
Experience in pharmaceutical/biotech industry (market access and/or health economics)
Understanding of US health care system and key partners (with an interest in formulary decision makers carrying out responsibilities for the selection of medications for coverage or reimbursement)
Understanding or familiarity with the US Value & Access organization, and how it works with other parts of the business
Interest in working with and communicating health care economic information (HCEI)
Internal Number: R-98494
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.